Four faces of cellular senescence
Open accessThe DOI matches its Crossref record; 133 of the 137 references it cites were found in a registry or an index; 10 of the 26 sources its claims cite were checked for support.
Abstract
Cellular senescence is an important mechanism for preventing the proliferation of potential cancer cells. Recently, however, it has become apparent that this process entails more than a simple cessation of cell growth. In addition to suppressing tumorigenesis, cellular senescence might also promote tissue repair and fuel inflammation associated with aging and cancer progression. Thus, cellular senescence might participate in four complex biological processes (tumor suppression, tumor promotion, aging, and tissue repair), some of which have apparently opposing effects. The challenge now is to understand the senescence response well enough to harness its benefits while suppressing its drawbacks.
Overview
CoChat Summary
## TL;DR
Cellular senescence is presented as an essentially irreversible growth arrest that suppresses tumor formation, but the paper argues it also has broader roles in tumor promotion, aging, and tissue repair. The authors frame these effects as arising from the senescence-associated secretory phenotype (SASP) and from the context in which senescent cells accumulate.
## Key findings
- Senescence is described as a crucial anticancer mechanism: in human and mouse premalignant lesions, senescent cells are abundant, but they are “markedly diminished” in the malignant tumors that develop from those lesions.
- Senescent cells can promote tumor progression in mouse xenografts: co-injection of senescent fibroblasts with premalignant epithelial cells enabled malignant cancer formation, and co-injection with fully malignant cells “markedly accelerates” tumor formation.
- Senescent cells may contribute to aging and degeneration: transgenic mice with chronically elevated p53 activity showed “shortened life span and premature aging,” including loss of fertility, osteoporosis, sarcopenia, dermal thinning, loss of subcutaneous fat, reduced hair growth, and retarded wound healing.
- In tissue repair, senescence appears beneficial: after acute liver injury, stellate cells undergo senescence, ECM production declines, MMP secretion increases, and mice impaired for senescence because of p53 or p16INK4a/p19ARF deficiencies developed “severe fibrosis” after injury.
## Methods
- This is a narrative review synthesizing prior studies across human tissues, mouse models, cell culture, and mouse xenografts.
- The paper compares senescent versus nonsenescent cells and summarizes experimental perturbations of p53, p16INK4a/pRB, Pten, Klotho, BubR1, p63, and CCN1 in relation to senescence phenotypes.
- Main analysis is interpretive and mechanistic: the authors connect published findings to a model in which senescence has temporally ordered phases, including early growth arrest, SASP induction, and later immune clearance or tissue-level effects.
## Limitations
- The paper itself states that evidence for senescence driving aging is “circumstantial,” and that cause-and-effect cannot yet be tested cleanly because organisms lacking senescence generally die prematurely of cancer.
- It also notes that there are “no definitive answers” for how senescence might promote late-life cancer.
- Evident from the text: many claims rely on mouse models, cell culture, and xenografts rather than direct demonstration in naturally occurring human disease.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
8 Valid · 1 Not valid · 8 Not checked · 28 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“thus p53 can be pro-aging or pro-longevity, depending on the physiological context (de Keizer et al., 2010).”
§ Four faces of cellular senescence > Cellular senescence and aging > Altered p53 function and aging.
What the sources say
- Supportedcites de Keizer et al., 2010 source
The paper states directly that p53 can be either pro-aging or pro-longevity depending on physiological context. It also explains that p53 can promote or retard aging depending on how its activity is regulated. (LLM, conf=0.95)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Low-level, chronic, “sterile” inflammation is a hallmark of aging that initiates or promotes most, if not all, major age-related diseases (Franceschi et al., 2007; Chung et al., 2009).”
§ Four faces of cellular senescence > Cellular senescence and aging > How might senescent cells promote age-related pathologies?
What the sources say
- Not checked — no full text of the sourcecites Franceschi et al., 2007 source
- Partly supportedcites Chung et al., 2009 sourceExperimental — accuracy not yet measured
The Introduction describes chronic, low-grade inflammation as a possible link between aging and the pathogenesis of many age-related diseases; the Conclusion calls it a primary factor underlying aging and numerous age-related diseases. The copy does not characterize the inflammation as “sterile,” and its references to many or numerous diseases do not substantiate “most, if not all.” Page numbers were not available in the indexed passages. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“which comprise a negative feedback loop to dampen NF-κB activity (Taganov et al., 2006; Freund et al., 2010).”
What the sources say
- Partly supportedcites Taganov et al., 2006 sourceExperimental — accuracy not yet measured
The Discussion (page not specified in our copy) proposes that NF-κB induces miR-146 genes, which could reduce IRAK1 and TRAF6 levels and thereby dampen pathway activity. The claim presents that proposed negative-feedback effect as established; the paper says further studies are needed to determine miR-146’s exact role. (LLM, conf=0.85)
- Supportedcites Freund et al., 2010 source
The “Chromatin organization” section states that miR-146a/b provide negative feedback that inhibits NF-κB activity. The “microRNAs” section likewise describes them as part of an NF-κB feedback loop. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Whatever the case, the examples above, and a growing list of similar studies (Collado and Serrano, 2010), argue that cellular senescence restrains cancer by imposing a cell-autonomous block to the proliferation of oncogenically damaged/stressed cells (Fig. 2).”
§ Four faces of cellular senescence > Cellular senescence and tumor suppression
What the sources say
- Supportedcites Collado and Serrano, 2010 source
The Introduction (page not provided) describes oncogenically stressed cells stopping division through a cell-cycle arrest and identifies oncogene-induced senescence as a tumour-suppressor mechanism. The Preface adds that senescence stably blocks proliferation and that progression to malignancy requires evading it. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The induction of these miRNAs may prevent the SASP from generating persistent acute (robust) inflammation, which, unlike low-level chronic inflammation, is designed to be self-limiting (Taganov et al., 2006).”
What the sources say
- Partly supportedcites Taganov et al., 2006 sourceExperimental — accuracy not yet measured
The Discussion proposes that induced miR-146 could dampen inflammatory signaling through a negative-feedback loop. It does not address the SASP or establish that these miRNAs prevent it from generating persistent acute inflammation; nor does it make the stated comparison with low-level chronic inflammation. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
30 more claims · 2 with their cited sources checked
Create a free account to see all 45 claims and every source verdict.
- It may state two separate claims as one. 4
- Probably not a substantial claim. 6
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased numbers of senescent cells with age are an important contributor to the age-associated increase in inflammation because senescent cells secrete a large number of pro-inflammatory proteins (senescence-associated secretory phenotype, or SASP) (Rodier and Campisi, 2011).”
From The Aging Epigenome (2016) · cites this paper as Rodier and Campisi, 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Senescence can be triggered by multiple mechanisms, including those resulting in ROS production and oxidative stress (Kuilman et al., 2010; Rodier and Campisi, 2011).”
From mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis (2012) · cites this paper as Rodier and Campisi, 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cells undergoing damage-induced senescence are often cleared by the immune system, as several SASP factors are cytokines and chemokines that can modulate the local immune environment.2,3,5,70,71”
From Paracrine roles of cellular senescence in promoting tumourigenesis (2018) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“which exhibit various senescence-related phenotypes, like increased size of nucleoli, enlarged and overloaded lysosome, and secretion of senescence-associated secretory phenotype (SASP) factors.5,6,7”
From Single-cell senescence identification reveals senescence heterogeneity, trajectory, and modulators (2024) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recent findings have uncovered an additional beneficial effect of the senescence response and accompanying SASP: the ability to promote optimal repair of damaged tissue (59, 91, 145–147).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [147]
23 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219 · cited 2×
“Moreover, to form a lethal tumor, cancer cells must acquire a greatly expanded growth potential and ability to proliferate while expressing activated oncogenes (Hanahan and Weinberg, 2000), traits that are suppressed by the senescence program.”
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 2×
“First, senescent cells increase with age in a variety of mammalian tissues (Dimri et al., 1995; Paradis et al., 2001; Melk et al., 2003; Erusalimsky and Kurz, 2005; Jeyapalan et al., 2007; Wang et al., 2009).”
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441 · cited 2×
“…al., 1991; Shay et al., 1991; Bond et al., 1994; Lin et al., 1998; Schmitt et al., 2002; Beauséjour et al., 2003; Collins and Sedivy, 2003; Oren, 2003; Herbig et al., 2004; Jacobs and de Lange, 2004; Ohtani et al., 2004; Chen et al., 2005; Campisi and d’Adda di Fagagna, 2007; Rodier et al., 2007).”
Self-citationTaganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317
Pleiotropy, natural selection, and the evolution of senescence.
Williams, G. C. (1957) · Evolution · doi:10.1111/j.1558-5646.1957.tb02911.x · Cited by 4,279
Cited by
Items 601–700 of 2,013
Lp, A., Zemelko, V. I., Domnina, A. P., Lyublinskaya, O. G., Zenin, V. V., Pugovkina, N. A., Kozhukharova, I. V., Borodkina, A. V., Гринчук, Т. М., Fridlyanskaya, I. I., et al. (2013) · Cell Stress and Chaperones · doi:10.1007/s12192-013-0463-6 · Cited by 57
Cellular senescence promotes progenitor cell expansion during axolotl limb regeneration
Yu, Q., Walters, H. E., Pasquini, G., Pal Singh, S., Lachnit, M., Oliveira, C. R., León-Periñán, D., Petzold, A., Kesavan, P., Subiran Adrados, C., et al. (2023) · Developmental Cell · doi:10.1016/j.devcel.2023.09.009 · Cited by 52
Ohtani, N. (2019) · The Journal of Biochemistry · doi:10.1093/jb/mvz055 · Cited by 55
Elevated skin senescence in young mice causes delayed wound healing
Thanapaul, R. J. R. S., Shvedova, M., Shin, G. H., Crouch, J. D., & Roh, D. S. (2022) · GeroScience · doi:10.1007/s11357-022-00551-1 · Cited by 52
Liu, Y., Shi, Y., Liu, Y., Pan, X., & Zhang, K. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0007-9 · Cited by 57
Weng, J.-H., Yu, C., Lee, Y., Lin, C., Chang, W., & Kuo, Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071092 · Cited by 52
“Enhancing radiosensitivity of cancer cells is one of the developing directions in cancer radiotherapy [3,4].”
BackgroundAs we age: Does slippage of quality control in the immune system lead to collateral damage?
Müller, L., & Pawelec, G. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.01.005 · Cited by 55
Tarabichi, M., Antoniou, A., Saiselet, M., Pita, J. M. G., Andry, G., Dumont, J. E., Detours, V., & Maenhaut, C. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9431-y · Cited by 52
“Even senescent cancer cells may harness wound healing responses to support the other cancer cells [235].”
BackgroundMammalian telomeres and their partnership with lamins
Burla, R., Torre, M. L., & Saggio, I. (2016) · Nucleus · doi:10.1080/19491034.2016.1179409 · Cited by 60
“They are not quiescent or terminally differentiated, and growth arrest is not reversed physiologically.(60) Senescence is induced by diverse stimuli, including persistent DNA damage and oxidative stress, but telomere erosion is a main and direct cause Figure 2.”
BackgroundYAP accelerates vascular senescence via blocking autophagic flux and activating mTOR
Pan, X., Wu, B., Fan, X., Xu, G., Ou, C., & Chen, M. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15902 · Cited by 52
Beach, T. A., Johnston, C. J., Groves, A. M., Williams, J. P., & Finkelstein, J. N. (2017) · Experimental Lung Research · doi:10.1080/01902148.2017.1318975 · Cited by 55
Gao, Y., Xu, J., Li, B., & Jin, Y. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.03.022 · Cited by 54
Gamma rays induce a p53-independent mitochondrial biogenesis that is counter-regulated by HIF1α
Bartoletti-Stella, A., Mariani, E., Kurelac, I., Maresca, A., Caratozzolo, M. F., Iommarini, L., Carelli, V, Eusebi, L. H., Guido, A., Cenacchi, G., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.187 · Cited by 51
“In fact g-rays elicit a DDR that, in presence of a functional p53, compels cells to undergo a temporary replicative arrest until repair.(15,40) One of the critical mediators of such arrest is p21, a transcriptional target of p53, which binds to and inhibits Cdk2/cyclin E complexes, thereby delaying the G1/S phase.”
BackgroundSenescent Microvesicles: A Novel Advance in Molecular Mechanisms of Atherosclerotic Calcification
Alique, M., Ramírez-Carracedo, R., Bodega, G., Carracedo, J., & Ramírez, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072003 · Cited by 53
“More specifically, the senescent status induced by oxLDL is characterized by a cell-cycle arrest and pro-inflammatory changes in gene expression [30] and several studies have revealed that senescent ECs are present in human atherosclerotic plaque [35,111,112].”
BackgroundSahu, S., Dattani, A., & Aboobaker, A. A. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.08.028 · Cited by 57
The senescence-associated secretory phenotype: Fueling a wound that never heals
Pulido, T., Velarde, M. C., & Alimirah, F. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111561 · Cited by 57
Jafari-Oliayi, A., & Asadi, M. H. (2019) · Cellular Oncology · doi:10.1007/s13402-019-00422-6 · Cited by 50
Eberhardt, K., Beleites, C., Marthandan, S., Matthäus, C., Diekmann, S., & Popp, J. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.6b04264 · Cited by 53
Breitenbach, M., Laun, P., & Jazwinski, S. M. (2011) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-2561-4 · Cited by 58
Identification of FoxR2 as an Oncogene in Medulloblastoma
Koso, H., Tsuhako, A., Lyons, E., Ward, J. M., Rust, A. G., Adams, D. J., Jenkins, N. A., Copeland, N. G., & Watanabe, S. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1523 · Cited by 53
“itor, is also expressed in most senescent cells (32).”
Wang, X., Zhang, J., Xiu, C., Yang, J., Fang, J., & Lei, Y. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/7151946 · Cited by 57
Novel immortal human cell lines reveal subpopulations in the nucleus pulposus
van den Akker, G., Surtel, D. A., Cremers, A., Rodrigues‐Pinto, R., Richardson, S. M., Hoyland, J. A., van Rhijn, L. W., Welting, T. J. M., & Voncken, J. W. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4597 · Cited by 56
“For example, SV40LTag interferes with pRB and TP53 function; both proteins are involved in the programming of senescence, which may be relevant for the degeneration process [48-52].”
New insights into the role of cellular senescence and chronic wounds
Yang, H., Zhang, X., & Bo, X. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1400462 · Cited by 60
Wentink, M. W. J., Mueller, Y. M., Dalm, V. A. S. H., Driessen, G. J. A., van Hagen, P. M., van Montfrans, J. M., van der Burg, M., & Katsikis, P. D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00446 · Cited by 55
“Hallmarks of senescence are permanent cell cycle arrest (18, 19) and resistance to apoptosis (20, 21).”
BackgroundWang, S., Wang, W., Liu, J., Song, Y.-H., Li, P., Sun, X., Cai, G., & Chen, X. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1618124 · Cited by 54
Identification of RNA-Binding Protein LARP4B as a Tumor Suppressor in Glioma
Koso, H., Yi, H., Sheridan, P. J., Miyano, S., Ino, Y., Todo, T., & Watanabe, S. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2308 · Cited by 50
“One of the cardinal features of the senescent phenotype is a change in cellular morphology (20).”
BackgroundMarthandan, S., Priebe, S., Baumgart, M., Groth, M., Cellerino, A., Guthke, R., Hemmerich, P., & Diekmann, S. (2015) · BioMed Research International · doi:10.1155/2015/731938 · Cited by 47
“However, on the other hand, senescence results in in vivo aging, weakening the function and renewal of stem cells [10].”
BackgroundNF90 coordinately represses the senescence-associated secretory phenotype
Tominaga-Yamanaka, K., Abdelmohsen, K., Martindale, J. L., Yang, X., Taub, D. D., & Gorospe, M. (2012) · Aging · doi:10.18632/aging.100497 · Cited by 49
“With advancing age, senescent cells accumulate in tissues and the SASP-elicited proinflammatory state is believed to have a complex influence on age-related conditions [6].”
BackgroundChronic Intermittent Hypoxia Triggers a Senescence-like Phenotype in Human White Preadipocytes
Polonis, K., Becari, C., Chahal, C. A. A., Zhang, Y., Allen, A. M., Kellogg, T. A., Somers, V. K., & Singh, P. (2020) · Scientific Reports · doi:10.1038/s41598-020-63761-7 · Cited by 53
Jung, S. H., Lee, M., Park, H. A., Lee, H., Kang, D., Hwang, H. J., Park, C., Yu, D., Jung, Y. R., Mi-Na, H. O. N. G., et al. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0114-7 · Cited by 50
Wang, P., Han, L., Shen, H., Wang, P., Lv, C., Zhao, G., Niu, J., Xue, L., Wang, Q. J., Tong, T., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310972111 · Cited by 56
“Senescent cells develop a senescence-associated secretory phenotype (SASP) by secretion of numerous cytokines, chemokines, and other proteins (9, 10).”
BackgroundDeacetylation of H4-K16Ac and heterochromatin assembly in senescence
Contrepois, K., Thuret, J., Courbeyrette, R., Fenaille, F., & Mann, C. (2012) · Epigenetics & Chromatin · doi:10.1186/1756-8935-5-15 · Cited by 60
“Although a biomarker totally specific to senescent cells has not been identified, senescent human cells often display some common characteristics including cell cycle arrest mediated by the p53 and/or Rb tumor suppressor pathways, morphological changes, induction of SA-β-galactosidase activity, enhanced secretion of s…”
Grandjenette, C., Schnekenburger, M., Karius, T., Ghelfi, J., Gaigneaux, A., Henry, E., Dicato, M. A., & Diederich, M. F. (2014) · Neoplasia · doi:10.1016/j.neo.2014.05.009 · Cited by 51
“Senescence induction was revealed by the significant increase in SA-β-gal activity, the enlarged and flattened morphology as well as the markedly increase of the lysosomal compartment, which consist of characteristic markers for senescent cells [29].”
BackgroundCell-extrinsic consequences of epithelial stress: activation of protumorigenic tissue phenotypes
Fordyce, C. A., Patten, K. T., Fessenden, T. B., DeFilippis, R., Hwang, E. S., Zhao, J., & Tlsty, T. D. (2012) · Breast Cancer Research · doi:10.1186/bcr3368 · Cited by 50
“Some of the secreted molecules we describe have been reported as part of the secretory phenotypes associated with senescent cells [9,40].”
BackgroundThe Urokinase Receptor: A Multifunctional Receptor in Cancer Cell Biology. Therapeutic Implications
Santi, A. L., Napolitano, F., Montuori, N., & Ragno, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084111 · Cited by 52
“Cellular senescence can also be induced by stimuli different from DNA damage, for instance by strong mitogenic signals, including those due to some oncoproteins, oxidative stress or loss of the PTEN tumor suppressor, a phosphatase that impairs pro-proliferative/pro-survival kinases [83].”
BackgroundCampisi, J. (2013) · Nature · doi:10.1038/nature12844 · Cited by 48
Self-citationRole of macrophage migration inhibitory factor in age-related lung disease
Sauler, M., Bucala, R., & Lee, P. J. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00339.2014 · Cited by 54
“Cellular senescence is a hallmark of aging and is characterized by cell cycle arrest, either from repetitive cell division or from accumulated damage from oxidative stress (27, 116).”
Synergism of BCL-2 family inhibitors facilitates selective elimination of senescent cells
Rysanek, D., Vašicová, P., Kolla, J. N., Sedlák, D., Anděra, L., Bártek, J., & Hodný, Z. (2022) · Aging · doi:10.18632/aging.204207 · Cited by 50
Nidadavolu, L. S., Niedernhofer, L. J., & Khan, S. A. (2013) · Aging · doi:10.18632/aging.100571 · Cited by 53
Growth hormone in the tumor microenvironment
Chesnokova, V., & Melmed, S. K. (2019) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000186 · Cited by 52
Lee, J. S., Yoo, J. E., Kim, H., Rhee, H., Koh, M. J., Nahm, J. H., Choi, J. S., Lee, K.-H., & Park, Y. N. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171922 · Cited by 53
Wu, Z., Yu, Y., Liu, C., Xiong, Y., Montani, J., Yang, Z., & Ming, X. (2015) · Aging · doi:10.18632/aging.100722 · Cited by 50
Tourlakis, M. E., Zhang, S., Ball, H. L., Gandhi, R., Liu, H., Zhong, J., Yuan, J. S., Guidos, C. J., Durie, P. R., & Rommens, J. M. (2015) · PLOS Genetics · doi:10.1371/journal.pgen.1005288 · Cited by 47
“p53 is a known driver of senescent cell cycle arrest [57,63] and increased levels of p53 have been reported in SDS patients [64].”
BackgroundCaveolae control the anti‐inflammatory phenotype of senescent endothelial cells
Powter, E. E., Coleman, P. R., Tran, M. H., Lay, A. J., Bertolino, P., Parton, R. G., Vadas, M. A., & Gamble, J. R. (2014) · Aging Cell · doi:10.1111/acel.12270 · Cited by 50
“Senescence plays a major role in many pathophysiological processes (Adams, 2009; Rodier & Campisi, 2011), including tumour suppression (Collado & Serrano, 2010), inhibition of liver damage (Krizhanovsky et al., 2008), and it is also linked to the progression of aging and age-related pathologies…”
BackgroundReed-Sternberg cells in Hodgkin’s lymphoma present features of cellular senescence
Gopas, J., Stern, E., Zurgil, U., Ozer, J., Ben-Ari, A., Shubinsky, G., Braiman, A., Sinay, R., Ezratty, J., Dronov, V., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.185 · Cited by 58
“is consistent with the large cell morphology characteristic of cells in senescence.(34) HL is known as a cytokine-producing tumor.”
ResultLuo, J., Sun, T., Liu, Z., Liu, Y., Liu, J., Wang, S., Shi, X., & Zhou, H. (2025) · International Journal of Oral Science · doi:10.1038/s41368-025-00380-w · Cited by 71
“158 The accumulation of senescent cells has been associated with an increase in the stromal SASP.”
From cellular senescence to age-associated diseases: the miRNA connection
Schraml, E., & Grillari, J. (2012) · Longevity & Healthspan · doi:10.1186/2046-2395-1-10 · Cited by 47
“However, some senescent cells also persist within tissues and are not eliminated by apoptosis or the immune system, such that their altered functional profile might alter tissue microenvironments in ways that can promote both cancer and aging phenotypes [22-24].”
BackgroundOgrodnik, M. B., & Gladyshev, V. N. (2023) · Nature Aging · doi:10.1038/s43587-023-00447-5 · Cited by 50
“There has been a number of hypotheses on the origin of cellular senescence in aging, including protection against cancer 17 , accumulation of damage incompatible with cell division 11 , high activity of cell expansion pathways 18 , a combination of both damage and expansion stimuli 19 , dysfunction…”
RNA methyltransferase NSUN2 promotes stress-induced HUVEC senescence
Cai, X. T., Hu, Y., Tang, H., Hu, H., Pang, L., Xing, J., Liu, Z., Luo, Y., Jiang, B., Liu, T., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8087 · Cited by 49
“Although SHC suppresses the growth of HDFs [6] and HUVECs (Figs 5-6), SHC may promote the proliferation of human prostate cancer cells [5], in agreement with the view that cell senescence can contribute to tumorigenesis [27].”
BackgroundDual inhibition of Akt and ERK signaling induces cell senescence in triple-negative breast cancer
He, Q., Xue, S., Tan, Y., Zhang, L., Shao, Q., Xing, L., Li, Y., Xiang, T., Luo, X., & Ren, G. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.02.004 · Cited by 47
Liu, Y., Pan, J., Pan, X., Wu, L., Bian, J., Lin, Z., Xue, M., Su, T., Lai, S., Chen, F., et al. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12577 · Cited by 52
“Published by FEBS Press and John Wiley & Sons Ltd. this process have been described in the literature where SASP factors were shown to support tumor cell invasion and metastasis in part by disrupting and remodeling the tissue structure (Copp e et al., 2008; Rodier and Campisi, 2011).”
MethodYoung, L. V., Wakelin, G., Cameron, A., Springer, S. A., Ross, J. P., Wolters, G., Murphy, J. P., Arsenault, M. G., Ng, S. Y., Collao, N., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202200289rr · Cited by 50
“Here we identify that following muscle injury, (1) a transient wave of cells demonstrating senescent characteristics such as senescence pathway expression, SAβgal activity, and SASP factor expression are present within skeletal muscle, (2) many cell types within skeletal muscle exhibit senescent characteristics with t…”
BackgroundAspirin Targets SIRT1 and AMPK to Induce Senescence of Colorectal Carcinoma Cells
Jung, Y. R., Kim, E. J., Choi, H. J., Park, J.-J., Kim, H.-S., Lee, Y., Park, M., & Lee, M. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.098616 · Cited by 50
“(Rodier and Campisi, 2011).”
Jonsson, M. K. B., Hartman, R. J. G., Ackers-Johnson, M., Tan, W. L. W., Lim, B., van Veen, T. A. B., & Foo, R. S. (2016) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2016.07.007 · Cited by 47
“Furthermore, a significant up-regulation of the classical marker for fibroblast senescence MMP3 (1,400-fold compared with control), as well as a subtle up-regulation of RB1 and TP53 (also markers of cell senescence), were noted in STAT1 knockdown aHCFs (Figure 5A).”
BackgroundMannino, M., Gomez-Roman, N., Hochegger, H., & Chalmers, A. J. (2014) · Stem Cell Research · doi:10.1016/j.scr.2014.05.001 · Cited by 52
“Moreover, one of the features of senescent cells is the acquisition of a secretory phenotype, which creates a niche that can affect adjacent cells (Rodier and Campisi, 2011).”
BackgroundThe origins of tumor-promoting inflammation
Bondar, T., & Medzhitov, R. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.07.016 · Cited by 47
“Indeed, senescence-associated secretory phenotype (SASP) is a common feature of senescent cells (Rodier and Campisi, 2011).”
BackgroundSenescent Mesenchymal Stem Cells: Disease Mechanism and Treatment Strategy
Liu, Y., & Chen, Q. (2020) · Current Molecular Biology Reports · doi:10.1007/s40610-020-00141-0 · Cited by 41
miRNAs in lung cancer: A link to aging
Zagryazhskaya, A., & Zhivotovsky, B. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.02.009 · Cited by 49
“Therefore, miR-146a/b was proposed to be nvolved in restraining senescence-induced inflammation which ay promote tumor progression (Rodier and Campisi, 2011).”
BackgroundSaneja, A., Nayak, D., Srinivas, M., Kumar, A., Khare, V. R., Katoch, A., Goswami, A., Vishwakarma, R. A., Sawant, S. D., & Gupta, P. N. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.10.028 · Cited by 47
Cheng, X. F., Yao, X., Xu, S., Pan, J., Yu, H., Bao, J., Guan, H., Lu, R., & Zhang, L. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.074 · Cited by 50
Wattanathamsan, O., Hayakawa, Y., & Pongrakhananon, V. (2019) · Phytotherapy Research · doi:10.1002/ptr.6422 · Cited by 47
“While p16 is widely recognized as a tumor suppressor and required for cell cycle regulation, the expression levels of p16, p53, and cleaved caspase‐3 were significantly upregulated in response to shikonin (Rodier & Campisi, 2011).”
BackgroundMaternal dyslipidemia during early pregnancy and epigenetic ageing of the placenta
Shrestha, D., Workalemahu, T., & Ayele, F. T. (2019) · Epigenetics · doi:10.1080/15592294.2019.1629234 · Cited by 50
Telomere Dysfunction in Idiopathic Pulmonary Fibrosis
Zhang, K., Xu, L., & Cong, Y. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.739810 · Cited by 54
“Accumulating evidence suggests that cellular senescence plays a critical role in aging-associated diseases (10, 16, 17).”
BackgroundOxidative stress induces senescence and sterile inflammation in murine amniotic cavity
Polettini, J., Richardson, L., & Menon, R. (2018) · Placenta · doi:10.1016/j.placenta.2018.01.009 · Cited by 50
“Although senescence is a normal biological process, it can be either beneficial or deleterious, since contributes for tumor suppression and is also linked to the aging related diseases [17].”
BackgroundMenicacci, B., Laurenzana, A., Chillà, A., Margheri, F., Peppicelli, S., Tanganelli, E., Fibbi, G., Giovannelli, L., Del Rosso, M., & Mocali, A. (2017) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glw336 · Cited by 47
“The ability of senescent human fibroblasts to promote carcinogenesis has been described and related to SASP factors in several papers by Campisi and colleagues (2,4–6, 11, 12, 20, 21).”
Onyema, O. O., Njemini, R., Forti, L. N., Bautmans, I., Aerts, J. L., Waele, M. D., & Mets, T. F. (2015) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2015.08.007 · Cited by 50
“vitro observations, which might, however, not be true reflections of in vivo characteristics (Rodier and Campisi, 2011).”
BackgroundSenolysis induced by 25-hydroxycholesterol targets CRYAB in multiple cell types
Limbad, C., Doi, R., McGirr, J., Ciotlos, S., Perez, K., Clayton, Z. S., Daya, R., Seals, D. R., Campisi, J., & Melov, S. (2022) · iScience · doi:10.1016/j.isci.2022.103848 · Cited by 45
“Senescent cells accumulate with age in many organs and create a pro-inflammatory milieu through a senescenceassociated secretory phenotype (SASP) (Rodier and Campisi, 2011).”
BackgroundSelf-citationBarbouti, A., Evangelou, K., Pateras, I. S., Papoudou-Bai, A., Patereli, A., Stefanaki, K., Rontogianni, D., Muñoz-Espín, D., Kanavaros, P., & Gorgoulis, V. G. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.02.005 · Cited by 44
Reduction of Premature Aging Markers After Gastric Bypass Surgery in Morbidly Obese Patients
Hohensinner, P. J., Kaun, C., Ebenbauer, B., Hackl, M., Demyanets, S., Richter, D., Prager, M., Wojta, J., & Rega‐Kaun, G. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3247-3 · Cited by 48
“SASP members include interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), several matrixmetalloproteases (MMPs), and the protease inhibitor plasminogen activator inhibitor-1 (PAI-1), which taken together support the inflammatory state of aging [9].”
BackgroundInfluentialThe role of cellular senescence in aging through the prism of Koch-like criteria
Yanai, H., & Fraifeld, V. E. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2017.10.004 · Cited by 45
“…(as suggested by the name itself) but rather reflects a basic cellular response to a milieu of stress insults (de Magalhaes and Passos, 2017; Rodier and Campisi, 2011) and is also an essential component of normal physiological processes such as development (Munoz-Espin et al., 2013) and…”
BackgroundThe hallmarks of aging in Ataxia-Telangiectasia
Aguado, J., Gómez‐Inclán, C., Leeson, H. C., Lavin, M. F., Shiloh, Y., & Wolvetang, E. J. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101653 · Cited by 48
“Cell senescence plays a role in development and tissue homeostasis, as well as in age-related degenerative and malignant diseases (Rodier and Campisi, 2011; Campisi, 2013).”
Cellular Senescence, Neurological Function, and Redox State
Maciel-Barón, L. Á., Moreno-Blas, D., Morales-Rosales, S. L., González-Puertos, V. Y., López-Díazguerrero, N. E., Torres, C., Castro-Obregón, S., & Königsberg, M. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7112 · Cited by 45
“…related to undesired outcomes include age-related illnesses, cancer and NDD (11), tissue disruption and dysfunction (55), chronic inflammation (56, 137), proliferation induction and accelerated tumor growth (24, 88), angiogenesis (129), and differentiation and epithelium– mesenchymal transition…”
InfluentialHarnessing α- l -fucosidase for in vivo cellular senescence imaging
Koo, S., Won, M., Li, H., Kim, W. Y., Li, M., Yan, C., Sharma, A. K., Guo, Z., Zhu, W., Sessler, J. L., et al. (2021) · Chemical Science · doi:10.1039/d1sc02259h · Cited by 47
Lewińska, A., Przybylski, P., Adamczyk‐Grochala, J., Błoniarz, D., Litwinienko, G., & Wnuk, M. (2022) · Cancers · doi:10.3390/cancers14030605 · Cited by 55
“The induction of a senescence program may have both beneficial and detrimental effects such as tumor suppression, wound healing and tissue remodeling, and tumor promotion and aging [2,3,5].”
BackgroundmiRNAs in stem cell aging and age-related disease
Choi, S. W., Lee, J. Y., & Kang, K. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.08.013 · Cited by 62
Guo, G., & Cui, Y. R. (2015) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-015-0053-5 · Cited by 53
“It is noteworthy that the reciprocal activity of the p53 and NF-κB is not exclusive because the coactivation of p53 and NF-κB was also observed under certain circumstances [21,93].”
BackgroundInfluentialCaveolin-1 promotes the tumor suppressor properties of oncogene-induced cellular senescence
Volonté, D., Vyas, A. R., Chen, C., Đačić, S., Stabile, L. P., Kurland, B. F., Abberbock, S. R., Burns, T. F., Herman, J. G., Di, Y. P., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.815902 · Cited by 49
Pawlikowski, J. S., Adams, P. D., & Nelson, D. M. (2013) · Journal of Cell Science · doi:10.1242/jcs.109728 · Cited by 70
Sosińska, P., Mikuła‐Pietrasik, J., Ryżek, M., Naumowicz, E., & Książek, K. (2014) · Biogerontology · doi:10.1007/s10522-014-9505-4 · Cited by 48
“Until now, a network of triggers and pathways controlling cell entry into this state has been identified, thus it is tempting to think that the mechanistic aspects of senescence have already been solved (Rodier and Campisi 2011).”
BackgroundZhu, X., Ye, H., Liu, J., Yu, R., & Jiang, J. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b04631 · Cited by 43
Cell senescence in cardiometabolic diseases
Grootaert, M. O. J. (2024) · npj Aging · doi:10.1038/s41514-024-00170-4 · Cited by 61
“14).”
BackgroundSenescence: Pathogenic Driver in Chronic Obstructive Pulmonary Disease
Rivas, M., Gupta, G., Costanzo, L., Ahmed, H., Wyman, A. E., & Geraghty, P. M. (2022) · Medicina · doi:10.3390/medicina58060817 · Cited by 51
“Although markers specific to the senescent state or universal to all senescent cells are not yet identified, most senescent cells express senescence-associated β-galactosidase (SA-βgal) activity, a result of increased lysosomal mass in senescent cells, and show an absence of proliferative markers and increased express…”
BackgroundDisruption of nucleocytoplasmic trafficking as a cellular senescence driver.
Park, J.-H., Ryu, S. J., Kim, B. J., Cho, H.-J., Park, C. H., Choi, H. J. C., Jang, E.-J., Yang, E. J., Hwang, J.-A., Woo, S.-H., et al. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00643-6 · Cited by 44
Secretome of Human Fetal Mesenchymal Stem Cell Ameliorates Replicative Senescence
Wang, B., Lee, W., Huang, B., Zhang, J., Wu, T., Jiang, X., Wang, C. C., & Li, G. (2016) · Stem Cells and Development · doi:10.1089/scd.2016.0079 · Cited by 50
“Unlike quiescent or terminally differentiated cells, senescent cells expressed p16 [4].”
Mapoung, S., Umsumarng, S., Semmarath, W., Arjsri, P., Srisawad, K., Thippraphan, P., Yodkeeree, S., & Dejkriengkraikul, P. (2021) · Plants · doi:10.3390/plants10122628 · Cited by 54
“These changes result from extrinsic processes that include ultraviolet (UV) radiation [1,2].”
BackgroundVassilieva, I. O., Kosheverova, V., Vitte, M. A., Kamentseva, R., Shatrova, A. N., Цупкина, Н. В., Skvortsova, E. V., Borodkina, A. V., Tolkunova, E. N., Nikolsky, N. N., et al. (2020) · Aging · doi:10.18632/aging.102737 · Cited by 50
Rizzo, M. G., Best, T. M., Huard, J., Philippon, M. J., Hornicek, F. J., Duan, Z., Griswold, A. J., Kaplan, L. D., Hare, J. M., & Kouroupis, D. (2023) · Cells · doi:10.3390/cells12101421 · Cited by 54
Jones, T. A., Jeyapalan, J. N., Forshew, T., Tatevossian, R., Lawson, A. R. J., Patel, S. N., Doctor, G. T., Mumin, M., Picker, S. R., Phipps, K. P., et al. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0266-3 · Cited by 48
“The expression of miR-146a is a late manifestation of senescence [43] and it is possible that the few pilocytic astrocytomas that do not show elevated expression of miR-146a have not reached a “mature” level of the senescent phenotype.”
Kanaki, T., Makrantonaki, E., & Zouboulis, C. C. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9392-x · Cited by 51
Liu, D., Richardson, G. D., Benli, F. M., Park, C., de Souza, J. V. B., Bronowska, A. K., & Spyridopoulos, I. (2020) · Clinical Science · doi:10.1042/cs20191213 · Cited by 50
Connecting chaperone-mediated autophagy dysfunction to cellular senescence
Moreno-Blas, D., Gorostieta-Salas, E., & Castro‐Obregón, S. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.11.001 · Cited by 45
Matrix and Backstage: Cellular Substrates for Viral Vaccines
Jordan, I., & Sandig, V. (2014) · Viruses · doi:10.3390/v6041672 · Cited by 46
“metastasis), and may augment telomere maintenance (by itself a transforming activity as it impacts senescence) [104,116].”
BackgroundKuo, M.-L., Sy, A. J., Xue, L., Chi, M., Lee, M. T. C., Yen, T., Chiang, M.-I., Chang, L., Chu, P. G., & Yen, Y. (2012) · Scientific Reports · doi:10.1038/srep00822 · Cited by 51
The changing epigenetic landscape of Mesenchymal Stem/Stromal Cells during aging
Cakouros, D., & Gronthos, S. (2020) · Bone · doi:10.1016/j.bone.2020.115440 · Cited by 44
Epigenetics and cardiovascular regenerative medicine in the elderly
Costantino, S., Camici, G. G., Mohammed, S. A., Volpe, M., Lüscher, T. F., & Paneni, F. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.09.188 · Cited by 45
Heparan sulfation is essential for the prevention of cellular senescence
Jung, S. H., Lee, H. C., Yu, D.-M., Kim, B., Park, S. M., Lee, Y., Park, H. J., Ko, Y.-G., & Lee, J.-S. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.107 · Cited by 45
“In addition, SASP facilitates tissue repair and remodeling, and elicits immune surveillance to eliminate senescent cells.(11,13,15) Thus, cellular senescence displays multiple effects on the tumor microenvironment of their neighboring tumor and normal cells.”
BackgroundThe Achilles’ heel of cancer survivors: fundamentals of accelerated cellular senescence
Shafqat, S., Arana‐Chicas, E., Shafqat, A., & Hashmi, S. K. (2022) · Journal of Clinical Investigation · doi:10.1172/jci158452 · Cited by 46
“The senescence-associated secretory phenotype (SASP), a characteristic transcriptomic signature expressed by many SCs of proinflammatory cytokines, chemokines, growth factors, and proteases, allows SCs to influence the tissue microenvironment in autocrine (cell-autonomous effects) and paracrine (non-cell-autonomous) m…”
BackgroundLiu, Y., Liu, X., Chen, X., Yang, Z., Chen, J., Zhu, W., Li, Y., Wen, Y., Deng, C., Gu, C., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2311028121 · Cited by 55
Nucleolar repression facilitates initiation and maintenance of senescence
Yang, L., Song, T., Chen, L., Soliman, H. H., & Chen, J. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1100777 · Cited by 46
“Secretion of cytokines and matrix metalloproteases by senescent mesenchymal cells (the SASP phenotype) may promote inflammation, accelerated aging, degenerative diseases, and tumor growth.(4) Removal of senescent cells in mice has been shown to reduce aging phenotypes.”
BackgroundDulic, V. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-239-1_2 · Cited by 42
Metadata
- Authors
- Rodier, F., & Campisi, J.
- Affiliations
- The Research Centre of the University of Montreal Hospital Centre/Institut du Cancer de Montréal, Montreal, Quebec, H2L 4M1 Canada 1
- Buck Institute for Research on Aging (US)
- Corresponding author
- Campisi, Judith
- ORCID
- Campisi, Judith
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2011-02-14
- Volume
- 192
- Issue
- 4
- Pages
- 547-556
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC3044123
- OpenAlex
- W2077450385
- Cited by
- 2,070
- References
- 137
- Citations by year
- 2026: 65 · 2025: 94 · 2024: 101 · 2023: 131 · 2022: 113 · 2021: 164 · 2020: 175 · 2019: 154 · 2018: 164 · 2017: 160 · 2016: 162 · 2015: 162 · 2014: 147 · 2013: 126 · 2012: 108
- FWCI
- 9.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Cell Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Funders
- U.S. Department of Energy
- Cancer Research Society
- Institut Du Cancer de Montréal
- National Institutes of Health
- National Cancer Institute
- Institute of Cancer Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- cellular senescence, tumor suppression, tumor promotion, aging, tissue repair, inflammation, tumor progression, senescence-associated secretory phenotype, senescence-associated inflammation
- MeSH terms
- Aging, Animals, Humans, Models, Biological, Neoplasms, Wound Healing, Signal Transduction, Cellular Senescence, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.